Protagonist Therapeutics, Inc·4

Mar 19, 4:01 PM ET

Waddill William D. 4

4 · Protagonist Therapeutics, Inc · Filed Mar 19, 2025

Insider Transaction Report

Form 4
Period: 2025-03-17
Transactions
  • Sale

    Common Stock

    2025-03-17$54.25/sh4,000$217,00013,130 total
Footnotes (1)
  • [F1]Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023.

Documents

1 file
  • 4
    tm259742-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT